Home
Mark Elliott Boulding, Exec. Vp and Clo: PTC Therapeutics PTCT Sell · Filed 06/22
Trade details
- Type
- Insider sale
- Amount
- $518,100
- Shares · price
- 6,600 sh · $78.50 a share
- Held after
- 107,122 sh
- Trade date
- 26/06/17
- Filed
- 26/06/22
- Days to filing
- 5 days
Sold 5.8% of holdings
- Share of holding sold
- 5.8%
PTC Therapeutics trades, last 26 weeks
What else happened in PTC Therapeutics around then
Filed or reported within 30 days of the trade day · 05/18~07/17Mark Elliott Boulding's recent trades
- Mark Elliott Boulding
Planned sale10b5-1 planPTC Therapeutics
Planned sale10b5-1 planPTC Therapeutics
PTCT
$201.7K
2,813 sh
$201.7K
Filed 08/17
Traded 08/17
- Mark Elliott Boulding
Planned sale10b5-1 planPTC Therapeutics
Planned sale10b5-1 planPTC Therapeutics
PTCT
$427.3K
5,079 sh
$427.3K
Filed 07/06
Traded 07/06
- Mark Elliott Boulding
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 planPTC Therapeutics
PTCT
$146.6K
1,850 sh
$146.6K
Filed 06/22
Traded 06/17
- Mark Elliott Boulding
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 planPTC Therapeutics
PTCT
$133.7K
1,703 sh
$133.7K
Filed 06/22
Traded 06/17
- Mark Elliott Boulding
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 planPTC Therapeutics
PTCT
$24.5K
309 sh
$24.5K
Filed 06/22
Traded 06/17